title: HIV-1 rev depolymerizes microtubules to form stable bilayered rings.
abstract: We describe a novel interaction between HIV-1 Rev and microtubules (MTs) that results in the formation of bilayered rings that are 44-49 nm in external diameter, 3.4-4.2 MD (megadaltons) in mass, and have 28-, 30-, or 32-fold symmetry. Ring formation is not sensitive to taxol, colchicine, or microtubule-associated proteins, but requires Mg(2+) and is inhibited by maytansine. The interaction involves the NH(2)-terminal domain of Rev and the face of tubulin exposed on the exterior of the MTs. The NH(2)-terminal half of Rev has unexpected sequence similarity to the tubulin-binding portion of the catalytic/motor domains of the microtubule-destabilizing Kin I kinesins. We propose a model wherein binding of Rev dimers to MTs at their ends causes segments of two neighboring protofilaments to peel off and close into rings, circumferentially containing 14, 15, or 16 tubulin heterodimers, with Rev bound on the inside. Rev has a strong inhibitory effect on aster formation in Xenopus egg extracts, demonstrating that it can interact with tubulin in the presence of normal levels of cellular constituents. These results suggest that Rev may interact with MTs to induce their destabilization, a proposition consistent with the previously described disruption of MTs after HIV-1 infection.
authors.affiliation: Laboratory of Structural Biology Research, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, USA.
authors.forename: N R
authors.initials: NR
authors.lastname: Watts
authors.forename: D L
authors.initials: DL
authors.lastname: Sackett
authors.forename: R D
authors.initials: RD
authors.lastname: Ward
authors.forename: M W
authors.initials: MW
authors.lastname: Miller
authors.forename: P T
authors.initials: PT
authors.lastname: Wingfield
authors.forename: S S
authors.initials: SS
authors.lastname: Stahl
authors.forename: A C
authors.initials: AC
authors.lastname: Steven
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D047630:Depsipeptides; D015694:Gene Products, rev / Q000378:metabolism*; D015658:HIV Infections / Q000378:metabolism* / Q000503:physiopathology; D015497:HIV-1 / Q000378:metabolism*; D007091:Image Processing, Computer-Assisted; D016547:Kinesins / Q000378:metabolism; D008870:Microtubules / Q000378:metabolism* / Q000473:pathology / Q000648:ultrastructure*; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000494:pharmacology; D017434:Protein Structure, Tertiary; D051381:Rats; D014981:Xenopus; D054321:rev Gene Products, Human Immunodeficiency Virus
chemical_list: D000970:Antineoplastic Agents; D047630:Depsipeptides; D015694:Gene Products, rev; D009842:Oligopeptides; D054321:rev Gene Products, Human Immunodeficiency Virus; D016547:Kinesins; C064570:dolastatin 10